Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
NCT01172353Phase 3Completed
- Sponsor
- Hospital São Lucas da PUCRS
- Start
- Jul 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium bicarbonate in contrast-induced nephropathy (CIN) (2 arms), sponsored by Hospital São Lucas da PUCRS. Primary endpoint: Contrast-induced Nephropathy at 48 hours. Started Jul 2004; status: completed.
02
Drugs
sodium bicarbonate
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT01172353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172353.